CME Institute

Don’t miss our Industry Forum Lunch TOMORROW at Muscular Dystrophy Association

Pre-register now: https://bit.ly/FSHDsymposium

Attending Muscular Dystrophy Association Clinical & Scientific Conference next week? Don’t miss our Industry Forum Lunch on Tuesday, March 5 from 12:00 – 1:30pm EST.

Pre-register now: https://bit.ly/FSHDsymposium

Take a 10-minute CME break to scroll through the data for LAIs vs. oral treatment options in schizophrenia.

Click to Start ➡️ https://bit.ly/3O7SPUz

Stop, Drop, and Scroll a CME Tweetorial for free credit! bit.ly/3oHHjGc

Learn how to evaluate the current therapies for Disease Psychosis (PDP), which impacts about 35% of PD patients.

Take a Tweetorial break for hump day!

Leading nephrology experts present A Rationale for Treating CKD with Combination Therapy in < 15 minutes ➡️ bit.ly/42chGga

Review the treatment standards for neuro clinicians caring for patients with epilepsy in this free video CME.

The Call to Arms: Seizure Clusters in the Real World: Treatment standards for neurologists and other clinicians caring for patients with epilepsy with emphasis on understanding epilepsy epidemiology, SUDEP and ILAE Classification updates, and therapeutic strategies.

New biomarker technology and advancements in treatment options can lead to earlier diagnosis of Alzheimer's and initiation of appropriate disease modifying therapies. Learn the latest for free CME!

Untangling Alzheimer's with Effective Diagnostic Tools and Novel Treatments New biomarker technology and advancements in treatment options can lead to earlier diagnosis of AD and initiation of appropriate disease modifying therapies.

Take a Sunday scroll through this Tweetorial and earn CME credit in just < 15 minutes!

Get Started ➡️ https://bit.ly/40cGPpl

An important and exciting paradigm shift in the treatment of depression has been created by esketamine, brexanolone, and zuranolone.

Click to implement faster-acting antidepressant treatment.

Rapid-Onset Therapies for MDD The new fast-acting antidepressants esketamine, an NMDA receptor antagonist, and positive allosteric modulators of GABAergic neurotransmission brexanolone and zuranolone have created an important and exciting paradigm shift in the treatment of depression.

New clinical trial data shows novel neuroactive steroids have the potential to change the treatment paradigm for postpartum and major depression.

New Clinical Trial Data on Neuroactive Steroids in MDD and PPD Studies evaluating neuroactive steroid GABA-A receptor positive allosteric modulators demonstrate promising results for the treatment of MDD and PPD.

There is real potential to reduce Alzheimer disease progression with these current and emerging agents.

🎥 Watch Now to earn free CME credit.

Diagnosing and Treating Alzheimer Disease During the Early Stage Many new therapies for early-stage AD have made their way onto the scene that can delay onset of the disease and/or slow down progression. Find out the how, what, when to better treat your patients with AD from specialists in the field.

Seizure clusters take a toll on patients’ QOL, emotional wellbeing, and career, making it imperative for neuro clinicians to put these new rescue treatments into practice.

Epilepsy Seizure Clusters: Therapeutic Advances and Emergency Plans | CME Institute Seizure clusters take a toll on patients' emotional wellbeing, work, and quality of life. Learn from experts about new rescue treatments.

Learn to assess patients with schizophrenia for needs that are not met with current treatment strategies in this psychiatry CME.

Unmet Treatment Needs of Patients with Schizophrenia | CME Institute Negative symptoms contribute to poor functional outcomes in schizophrenia. Evaluating different symptom domains and understanding the disorder's reward circuitry can help with intervention and patients' leading more fulfilling lives.

Review the impact of side effects on adherence to schizophrenia treatment, which can have the greatest impact on adherence for patients.

Impact of Side Effects on Adherence to Schizophrenia Treatment | CME Institute Side effects from medication have the greatest impact on adherence for patients with Schizophrenia. They lower quality of life, daily functioning, and satisfaction.

These therapeutic advances for epileptic seizure rescue can make a very real impact on patients' lives. Click to learn the latest available rescue therapies and medications.

Therapeutic Advances for Epileptic Seizure Rescue | CME Institute Neurologists and other clinicians can improve care by identifying individuals who are susceptible to seizure clusters and educating them on rescue therapies and medications.

New treatments for myasthenia gravis have potential to be both effective and well tolerated, addressing the trade-off in treatment selection.

Click to learn the role of antibodies in gMG treatment.

The Role of Antibodies in the Myasthenia Gravis Treatment Landscape | CME Institute Symptoms and disease pathophysiology of myasthenia gravis (MG) vary considerably with each patient, and their individual preferences and priorities add to the need for individualized treatment of this autoimmune disease. Research in MG has grown substan...

60% of patients with bipolar disorder who present with depression are misdiagnosed as recurrent unipolar depression.

To better individualize care, complete this brief, free CME!

Individualizing Treatment Selection for Patients With Bipolar Depression Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.

Gain a real-world view of the QOL and treatment options available to those living with Duchenne muscular dystrophy in this free video CME.

A Tailored Approach to Symptom Management in Patients with Duchenne MD A detailed, modern digest of key advances in the diagnosis, treatment, and management of patients with Duchenne muscular dystrophy.

Stop, Drop, and Scroll a Tweetorial!

Learn to optimize management of care for Rett syndrome, a rare neurodevelopmental disease that primarily affects females.bit.ly/3TkyQnR

Review the subtle symptoms of tardive dyskinesia and the huge impact early recognition and intervention can make for the patient's QOL.

🎥 Watch Now:

Tardive Dyskinesia: The Huge Impact of Early Recognition and Intervention Clinicians should screen regularly for signs and symptoms of tardive dyskinesia and educate patients and caregivers on what to look for and report, leading to earlier intervention and better quality of life.

Research on the pathophysiology of depression that includes the glutamatergic system and GABA signaling is ushering in a new era for rapidly acting antidepressants.

Click to learn the latest clinically relevant insights.

Antidepressants and Duration Until Onset Pharmacology for MDD is limited by low efficacy, delayed response, and side effects. Research on the pathophysiology of the disease that includes the glutamatergic system and GABA signaling is ushering in a new era for rapidly acting antidepressants.

Here's a 💡 novel idea! Combat the 90% nonadherence rate by involving patients with bipolar disorder in the design of their own treatment strategies.

Click to watch now: 🎥

Addressing Unmet Needs in the Diagnosis and Treatment of Bipolar Disorder Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are updated and new treatments become available, developing individualized treatment regim...

Review 3 patient cases with regular screening of UACR and the addition of finerenone to SGLT2 inhibitors to make an impact on T2D patients at risk for CKD!

Examining CKD Screening and Real-World Practice Regular screening of UACR and adding finerenone to SGLT2 inhibitors can greatly impact T2D at risk for CKD. Join faculty as they discuss three patient cases.

This is the future of schizophrenia treatment: An in-depth exploration of novel, non-dopaminergic therapies transforming the standard of care for patients with positive and negative symptoms.

Watch Now!

Non-Dopaminergic Mechanisms for Schizophrenia Symptom Management What is the future of schizophrenia treatment? An in-depth exploration of novel, non-dopaminergic therapies transforming the standard of care for patients with schizophrenia's positive and negative symptoms.

🚨 70% of patients with epilepsy DO NOT have a seizure response plan!

This CME shows how neuro clinicians can help patients and caregivers address this critical gap for rescue meds and emergency planning.

New Options for Rescue Treatment in Individuals With Epilepsy Seizure Clusters Drs Detyniecki and Penovich identify the need for emergency seizure response plans and the new rescue treatment options that may easily be used by patients with epilepsy and their caregivers.

Stop, Drop, and Scroll a Tweetorial!

Earn free CME credit by learning the subtle symptoms of tardive dyskinesia, and how early intervention can make a huge impact on care and QOL.

Get Started ➡️ bit.ly/40hH573

To optimize care for Rett syndrome, implement therapeutics with a multidisciplinary approach and focus on emerging therapies.

Watch this free CME to learn more about this rare disease.

Improving Clinician Awareness of Rett Syndrome and Optimizing Management Because of the multiple comorbidities associated with Rett syndrome, clinicians are advised to incorporate clinical guidelines that suggest implementing therapeutics with a multidisciplinary approach and with an eye toward new and emerging therapies.